$42.39
0.69% day before yesterday
Nasdaq, Jan 02, 10:00 pm CET
ISIN
US92337F1075
Symbol
VCYT

Veracyte Inc Stock price

$42.39
-3.77 8.17% 1M
+14.81 53.70% 6M
+0.29 0.69% YTD
+1.95 4.82% 1Y
+18.66 78.63% 3Y
-4.95 10.46% 5Y
+35.60 524.30% 10Y
+29.14 219.92% 20Y
Nasdaq, Closing price Fri, Jan 02 2026
+0.29 0.69%
ISIN
US92337F1075
Symbol
VCYT
Industry

Key metrics

Basic
Market capitalization
$3.4b
Enterprise Value
$3.0b
Net debt
positive
Cash
$366.4m
Shares outstanding
79.0m
Valuation (TTM | estimate)
P/E
111.6 | 79.9
P/S
6.8 | 6.5
EV/Sales
6.0 | 5.8
EV/FCF
30.4
P/B
2.7
Financial Health
Equity Ratio
90.5%
Return on Equity
2.0%
ROCE
3.8%
ROIC
4.8%
Debt/Equity
0.0
Financials (TTM | estimate)
Revenue
$495.1m | $517.8m
EBITDA
$56.9m | $133.8m
EBIT
$48.6m | $33.5m
Net Income
$30.2m | $41.9m
Free Cash Flow
$98.3m
Growth (TTM | estimate)
Revenue
16.4% | 16.2%
EBITDA
136.3% | 377.3%
EBIT
433.6% | 72.8%
Net Income
420.4% | 74.6%
Free Cash Flow
72.7%
Margin (TTM | estimate)
Gross
68.5%
EBITDA
11.5% | 25.9%
EBIT
9.8%
Net
6.1% | 8.1%
Free Cash Flow
19.8%
More
EPS
$0.4
FCF per Share
$1.2
Short interest
7.4%
Employees
824
Rev per Employee
$540.0k
Show more

Is Veracyte Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,082 stocks worldwide.

Veracyte Inc Stock Analysis

Unlock Scores for Free

Analyst Opinions

19 Analysts have issued a Veracyte Inc forecast:

15x Buy
79%
3x Hold
16%
1x Sell
5%

Analyst Opinions

19 Analysts have issued a Veracyte Inc forecast:

Buy
79%
Hold
16%
Sell
5%

Financial data from Veracyte Inc

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '25
+/-
%
495 495
16% 16%
100%
- Direct Costs 156 156
16% 16%
32%
339 339
17% 17%
69%
- Selling and Administrative Expenses 216 216
8% 8%
44%
- Research and Development Expense 67 67
0% 0%
14%
57 57
136% 136%
11%
- Depreciation and Amortization 8.34 8.34
44% 44%
2%
EBIT (Operating Income) EBIT 49 49
434% 434%
10%
Net Profit 30 30
420% 420%
6%

In millions USD.

Don't miss a Thing! We will send you all news about Veracyte Inc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Veracyte Inc Stock News

Neutral
Business Wire
5 days ago
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Veracyte, Inc. (Nasdaq: VCYT), a leading cancer diagnostics company, announced today that management will present at the 44th Annual J.P. Morgan Healthcare Conference on Thursday, January 15, 2026, at 9:45 a.m. Pacific Time. Live audio webcasts of the company's presentations will be available by visiting Veracyte's website at http://investor.veracyt...
Neutral
Business Wire
about 2 months ago
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Veracyte, Inc. (Nasdaq: VCYT) a leading cancer diagnostics company, announced today it will participate in the following investor conferences. Wolfe Research Healthcare Conference – New York, NY Fireside Chat on November 17th at 10:00 a.m. Eastern Time Jefferies Global Healthcare Conference – London, UK Fireside Chat on November 20th at 11:30 a.m. G...
Neutral
Seeking Alpha
about 2 months ago
Veracyte, Inc. ( VCYT ) Q3 2025 Earnings Call November 4, 2025 4:30 PM EST Company Participants Shayla Gorman - Director of Investor Relations Marc Stapley - CEO & Director Rebecca Chambers - Executive VP & CFO John Leite - Global Chief Commercial Officer Phillip Febbo - Chief Scientific & Medical Officer Conference Call Participants Douglas Schenkel - Wolfe Research, LLC Puneet Souda - Leerink...
More Veracyte Inc News

Company Profile

Veracyte, Inc. engages in the research, development and commercialization of diagnostic products. The firm's portfolio includes Afirma, Percepta, and Envisia. It intends to treat thyroid cancer, improve lung cancer screening, and clarify the diagnosis of idiopathic pulmonary fibrosis. The company was founded by Bonnie H. Anderson and Y. Douglas Dolginow on August 15, 2006 and is headquartered in South San Francisco, CA.

Head office United States
CEO Marc Stapley
Employees 824
Founded 2006
Website www.veracyte.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today